Immunomedics (IMMU) - moderated | Stock Discussion Forums

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical
Immunomedics (IMMU) - moderated

An SI Board Since September 2006

Posts	SubjectMarks	Bans	Symbol
63362	356	15	IMMU

Emcee: idahoranch1	Type: Moderated

Introduction Market Data Compact

Go to reply# or date (mm/dd/yy):

Reply	Message Preview	From	Recs	Posted
63199	SRPT trading halted AH?	erippetoe	-	7/28/2025
63198	Well GG, you were spot on about a $2 pop today. I almost think you’ve been manip	Olecranon	1	7/28/2025
63197	As much as I would like to feel that optimism, I’m more pessimistic every day. P	Olecranon	1	7/28/2025
63196	That should be worth a $2+ pop. More importantly, it draws attention to this qua	ghettogoulash	1	7/28/2025
63195	Vinay Prasad Is a Bernie Sanders Acolyte in MAHA Drag A top FDA appointee who do	sukit	3	7/27/2025
63194	The Sarepta Mugging and Drug Innovation The Trump FDA tries to kill a therapy th	sukit	4	7/27/2025
63193	Can anyone share the text from this article? Thanks The Sarepta Mugging and Dru	ghettogoulash	-	7/27/2025
63192	Fwiw, Ingram said in May that it was the FDA who suggested adding Sirolimus to t	ghettogoulash	3	7/26/2025
63191	Sarepta Therapeutics Provides Clarifying Statement on ELEVIDYS BUSINESS WIRE Ju	luckydog88	1	7/26/2025
63190	Thanks GG for posting this. What I found particularly interesting is that this m	bodish	1	7/25/2025
63189	REUTERS Jul-25-2025 5:50 p.m. ET July 25 (Reuters) - The U.S. Food and Drug Ad	luckydog88	-	7/25/2025
63188	REUTERS Jul-25-2025 6:42 a.m. ET July 25 (Reuters) - Europe's medicines re	luckydog88	1	7/25/2025
63187	Great finds GG. AF’s prognistication that this could completely sink Sarepta see	Olecranon	1	7/25/2025
63186	Yet another mother explains the risk/reward elegantly. These Elevidys stories ar	ghettogoulash	2	7/24/2025
63185	Roche also wonders wtf is up with the FDA. Meanwhile, Laura Loomer is on a crusa	ghettogoulash	3	7/24/2025
63184	Preceding that, more fake news: [graphic][graphic][graphic]	ghettogoulash	1	7/24/2025
63183	found this hitting the wire at 3:22 Endpoints News Biotech/Pharma Reporter Zac	luckydog88	2	7/24/2025
63182	Added more SRPT a little while ago in the mid-10's. But I was afraid to buy	Olecranon	-	7/24/2025
63181	SRPT: talk about a divergence of analyst opinions this morning ........ Citigr	luckydog88	1	7/24/2025
63180	Interesting that Goldman Sachs just downgraded IOVA (to $1.00), we all remember	Stikkmann	1	7/23/2025
63179	Anyone following IOVA? Seems to be moving with good volume. Thoughts? TIA	CFL Invest 1	1	7/22/2025
63178	I wasn't crazy about Sarepta defying FDA brass, but I could see why they did	ghettogoulash	1	7/22/2025
63177	CAMBRIDGE, Mass.--(BUSINESS WIRE)-- Sarepta Therapeutics, Inc. (SRPT) , the lead	luckydog88	-	7/21/2025
63176	Don't know much about RFK, but his recent comments do not seem threatening,	ghettogoulash	-	7/21/2025
63175	Elevedis is in ambulatory patients has quickly jumped over PMO as SRPT’s greates	Olecranon	-	7/21/2025

Go to reply# or date (mm/dd/yy):